Basic Information
ALZpath is a developer of innovative diagnostic solutions for Alzheimer's disease. The company will accelerate the analytical and clinical validation of ALZpathDx, a proprietary assay for quantifying phosphorylated tau217 (pTau217), which is a highly accurate diagnostic biomarker for Alzheimer's disease.
ALZpath, Inc.
California,United States of America
unclear
January 01, 2020
inquiry@alzpath.bio
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios